A juvenile polyp on screening colonoscopy
Spyridon Vrakas; Simone Ignatova; Giorgos Karapiperis; Sofia Kartsoli; Dimitrios Karapiperis
Abstract
The most common polyps in the large bowel are adenomas and serrated polyps. Diamond
The clinical management varies according to their localization and size. Polyps in the large bowel are detected during endoscopy and removed with polypectomy, in the stomach and duodenum during gastroscopy and in the small bowel with device-assisted enteroscopy.
The risk of cancer when detecting one juvenile polyp is not clear. A single juvenile polyp is believed to not increase the risk of cancer. This is based on a few studies with a limited number of patients. Nugent et al.
Several hypotheses exist for the mechanism by which juvenile polyps become malignant. The first hypothesis is that polyps follow a hamartoma-carcinoma sequence similar to adenoma-carcinoma. They grow more prominent, dysplasia develops, and eventually transforms into invasive carcinoma. The second theory is that cancer results not from the polyps themselves but from asymmetrical stem cell divisions, leading to altered stem cell lineage turnover rates and accelerated progression to cancer. The third hypothesis is based on the idea that juvenile polyps may develop foci of adenomas, which then can proceed to malignant degeneration.
Juvenile polyps are most commonly diagnosed in children during their first decade of life. They are commonly found in the rectum and present with rectal bleeding. Less common presentations include abdominal pain, diarrhea, constipation, anemia, and prolapse of polyp through the rectum. In adults, rectal bleeding is the most common symptom, followed by abdominal pain and prolapse.
It is important to distinguish patients with one juvenile polyp from patients with inherited polyposis syndromes. Patients with hamartomatous polyposis syndromes (HPS) have multiple polyps throughout the GI tract, extraintestinal findings (extraintestinal cancers, epistaxis, telangiectasias) and a high risk of cancer. Diagnosis of HPS is based on clinical criteria, and genetic testing is used to confirm the diagnosis. Juvenile polyposis syndrome is a rare hereditary disease characterized by multiple hamartomatous polyps throughout the gastrointestinal tract and the risk for colorectal and gastric cancer is increased. Ιt is important to distinguish the occurrence of one polyp from juvenile polyposis syndrome (JPs), which can be diagnosed based on the following clinical criteria: i) more than 5 juvenile polyps in the GI tract, ii) multiple juvenile polyps throughout the GI tract, or iii) one or more juvenile polyps together with a family history of JPs. Mutations are detected in SMAD4 and BMPR1A genes in 20-30% of cases.
Keywords
References
1 Diamond M. Adenoma of the rectum in childrenreport of a case in a thirty month old girl. Am J Dis Child. 1939;57:360-67.
2 Helwig EB. Adenoma of the large bowel in children. Am J Dis Child. 1946;72:289-95.
3 Jelsig AM. Hamartomatous polyps: a clinical and molecular genetic study. Dan Med J. 2016;63(8):B5280. PMid:27477802.
4 Brosens LA, Langeveld D, Hattem WAV, et al. Juvenile polyposis syndrome. World J Gastroenterol. 2011;17(44):4839-44. PMid: 22171123.
5 Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology. 1993;105(3):698-700.
6 Cone MM. Hamartomatous polyps and associated syndromes. Clin Colon Rectal Surg. 2016;29(4):330-5.
7 Jelsig AM, Ousager LB, Brusgaard K, Qvist N. Juvenile polyps in Denmark from 1995 to 2014. Dis Colon Rectum. 2016;59(8):751-7.
8 Brosens LA, Van Hattem A, Hylind LM, et al. Risk of colorectal cancer in juvenile polyposis. Gut. 2007;56(7):965-7.
Submitted date:
11/11/2022
Accepted date:
11/28/2022
Publication date:
12/22/2022